Trademark: 79320342
Word
LBIOME
Status
Registered
Status Code
700
Status Date
Tuesday, April 25, 2023
Serial Number
79320342
Registration Number
7033011
Registration Date
Tuesday, April 25, 2023
Mark Type
3000
Filing Date
Thursday, May 20, 2021
Published for Opposition
Tuesday, February 7, 2023

Trademark Owner History
Adare Pharmaceuticals SAS - Original Registrant

Classifications
40 Customized manufacture, for third parties, of pharmaceuticals, nutritional and food supplements featuring live or inactivated microorganisms; manufacture of ingredients comprising inactivated, heat-treated Lactobacillus strains and their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; custom manufacture, for third parties, of pharmaceutical and nutritional supplemental ingredients, namely, enriched culture medium and heat-treated microorganisms; manufacture of pharmaceutical ingredients, namely, heat-treated micro-organisms, for preparation of tablets, capsules, powders, injectable products, suspensions, liquids, for medical and veterinary use
5 Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, autisms, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, obsessive-compulsive disorders, addiction, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, necrotizing enterocolitis, enteritis, skin inflammation, and skin infections, and veterinary pharmaceutical preparations for the treatment and prevention of gastrointestinal infections, dysbiosis, diarrhea, irritable bowel syndrome, inflammatory bowel disease, abdominal pain, colitis, vaginal infections, obesity, allergy, stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, fibromyalgia, cancer, post-traumatic stress, mucosal and systemic inflammation, enteritis, skin inflammation, and skin infections; dietetic foods adapted for medical and veterinary use; bacterial preparations for medical and veterinary use; probiotic bacteria preparations for medical use; foodstuffs and nutritional and food supplements featuring live or inactivated microorganisms, namely, nutritional supplements, enzyme food supplements, dietary food supplements, food supplements for humans and animals; ingredients based on inactive bacteria preparations and heattreated and heat-stabilized bacteria preparations, namely, Lactobacillus strains in combination with fermentation medium featured as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; ingredients based on combinations of inactivated and heat-treated Lactobacillus delbrueckii and Lactobacillus fermentum and fermentation medium sold as a component ingredient of pharmaceutical and veterinary preparations and nutritional and dietary supplements; additives in the nature of dietary supplements for humans or for animals; ferments for medical or veterinary use with postbiotic or probiotic effects
42 Medical and pharmaceutical research and development in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; scientific research and development; bacteriological scientific research and consultation; provision of information and data relating to medical and veterinary research and development; provision of scientific and technological information in the field of microbiology, immunology, mucosal immunology, gastroenterology, internal medicine, psychology, psychiatry, neurology, behavioral science, inflammatory disorders, sarcopenia, health by nutrition, dermatitis, allergies, infectiology, endocrinology, postbiotics; design and development of pharmaceuticals, nutritional supplements and dietetic supplements comprising living and inactivated microorganisms; research and development of formulations, namely, pharmaceuticals, nutritional supplements, and dietary supplements for the administration of heat-treated Lactobacillus strains combined with their fermentation medium, namely, Lactobacillus LB, consisting of a combination of Lactobacillus delbreuckii and Lactobacillus fermentum as ingredients; research and development of pharmaceutical ingredients based on enriched culture medium and heat-treated bacteria, namely, Lactobacillus strains; research and development of formulations, namely, pharmaceutials, nutritional supplements, and dietetic supplements, based on enriched culture medium and heat-treated micro-organisms; technological consultation in the field of bacteria-based ingredients and in the field of postbiotics
The mark consists of the stylized wording "LBIOME" and design featuring the letters LB semi-connected and the letter O featured as a circle with ten small ovals, on a tilt, inside the circle.
Color is not claimed as a feature of the mark.

Trademark Events
Nov 4, 2023
New Representative At Ib Received
Oct 6, 2023
Teas Change Of Correspondence Received
Oct 6, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2023
Final Decision Transaction Processed By Ib
Aug 2, 2023
Final Disposition Notice Sent To Ib
Aug 2, 2023
Final Disposition Processed
Jul 25, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 25, 2023
Notice Of Registration Confirmation Emailed
Apr 25, 2023
Registered-Principal Register
Mar 14, 2023
Notification Of Possible Opposition - Processed By Ib
Feb 22, 2023
Notification Of Possible Opposition Sent To Ib
Feb 22, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Feb 7, 2023
Changes/Corrections After Pub Approval Entered
Feb 7, 2023
Notification Processed By Ib
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Feb 1, 2023
Assigned To Petition Staff
Feb 1, 2023
Post Publication Amendment Received
Jan 30, 2023
Assigned To Petition Staff
Jan 18, 2023
Notification Of Possible Opposition Sent To Ib
Jan 17, 2023
Teas Post Publication Amendment Received
Jan 18, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 4, 2023
Approved For Pub - Principal Register
Dec 31, 2022
Teas/Email Correspondence Entered
Dec 30, 2022
Correspondence Received In Law Office
Dec 30, 2022
Teas Request For Reconsideration Received
Sep 3, 2022
Notification Of Final Refusal Emailed
Sep 3, 2022
Final Refusal E-Mailed
Sep 3, 2022
Final Refusal Written
Aug 5, 2022
Teas/Email Correspondence Entered
Aug 5, 2022
Correspondence Received In Law Office
Aug 5, 2022
Teas Response To Office Action Received
Jul 26, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 26, 2022
Teas Change Of Correspondence Received
Jul 26, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 26, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 26, 2022
Teas Change Of Owner Address Received
Mar 27, 2022
Refusal Processed By Ib
Mar 9, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 9, 2022
Refusal Processed By Mpu
Feb 11, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 10, 2022
Non-Final Action Written
Feb 1, 2022
Assigned To Examiner
Sep 28, 2021
Application Filing Receipt Mailed
Sep 24, 2021
New Application Office Supplied Data Entered
Sep 16, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24